Here's How Biotech Company Quantgene Plans to Extend Human Life by 10 Years Within a Decade

Rachel Uranga

Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.

quantgene

Jo Bhakdi thinks he can extend life with data.

Over the past years, the trained economist and co-founder of Quantgene has helped create a blood test that screens for early signs of some of the deadliest cancers, using millions of culled data points.

"We have a bigger vision behind this," Bhakdi said. "It's what I call decades in a decade — to extend the average human lifespan by ten years in the next ten years."


Quantgene has been developing so-called "liquid test" that can pinpoint the origin of multiple types of cancer by identifying their cellular mutations using artificial intelligence analytics and big data.

The project began five years ago at a U.C. Berkeley lab. Bhakdi partnered with co-founder Monika Hagen to create a system that would screen cancer using algorithms.

Late this year, Bhakdi and Hagen expect to roll out an early cancer screening subscription plan to consumers for an annual cost of around $2,200, pending regulatory approval. And they specifically came to Los Angeles, an image-conscious city that's embraced the idea of wellness, to launch it.

Blood tests are not a new technology for cancer screening, but Quantgene and others are trying to create a more precise tool to identify cancer in its earliest stages by finding mutation patterns that point to the disease. And in the process lower cancer death rates in the U.S.. This year, an estimated 600,000 people will die of the disease. Another 1.6 million will get the grim diagnosis. It's the second biggest killer of Americans year in and year out.

Most blood tests are currently used when doctors already know where the cancer exists, mostly in order to track its progression.

Quantgene founders Jo Bhakdi and Monika Hagen

The new tests examine fragments of DNA that break loose in the bloodstream. Quantgene looks at the different mutations of these cells to identify patterns that signal early forms of cancer or other diseases. The company plans to sell the system as part of a line of tiered-price testing called "Serenity" that includes genetic counseling and profiles.

Quantgene is branding the complex sequencing and AI process that analyzes these mutations the "Griffin Deep Genomics Platform." The company has raised more than $13 million, and expects to raise a Series B round this fall. Bhakdi believes it could upend how people test for cancer. But it has competition.

Amazon-backed, Menlo Park-based Grail Inc. has raised nearly $2 billion. In March, the Silicon Valley company released a report that said it could detect 50 types of cancer across all stages, with a false-positive rate below 1%. The company said it can find its location with 93% accuracy. But finding early-stage cancer — the type that actually save lives — has proven elusive.

Of the 12 deadly cancer types that make up 63% of deaths in the U.S., Grail reported a detection rate of 67% for stages one to three. The company's test is expected to be available within 12 months. A spokeswoman said in an email, it's "too early to comment on cost, however, our principal goal is to ensure broad access to our test, and we hope to make this ground breaking technology available to as many people as possible." Investors include Bill Gates, Bristol-Myers Squibb and Merck.

"The problem with a lot of these liquid biopsy technologies right now — Grail and others — is that they are not really good at detecting cancers at the earliest stages. Because there just isn't that much tumor material in the blood," said Timothy Rebbeck, director of the Zhu Family Center for Global Cancer Prevention at Harvard. "So, it's not to say that it couldn't be done. It's just the right now the technology is not refined enough to do it that really well."

Getting to Cancer Screening at Earlier Stages

For the last few decades, physicians have screened individual organs for signs of cancer, trying to suss out whether a patient has a cancerous growth on the pancreas or breast or lung. These early screenings, coupled with advances in cancer treatments, have been credited with a decline in U.S. deaths related to cancer.

"The median point of diagnosis in these 1.6 million is between stage three and stage four.

If you can shift that point of stage two and one, you would be saving 400,000 people a year," Bhakdi said. "That's crazy if you think about that."

Bhakdi, who comes from a family of scientists and doctors, began the search less than a month before his own mother was diagnosed with stage four colon cancer.

At the time, a family member asked his help in solving a genomic question about whether one could determine if a random, isolated cell was cancer. The answer is very difficult to get. It lays in sequencing the cell's DNA and then comparing it to thousands of others. That ability to compare cells with a massive data trove is now at the heart of their company.

A flow cell used for deep-sequencing produces 6 billion data points per patient sample.Courtesy Quantgene

Bhakdi believes it would have saved his mother.

"If you are diagnosed with colon cancer at stage one, you have a 94% survival rate," he said. "In stage four, you have an 11% survival rate."

Sidestepping Insurers in Santa Monica

One of the best ways to bring down deaths is to diagnose cancer early, said Rebbeck. But even when these technologies are developed for widespread use they could exacerbate disparities for the poor, underserved and uninsured. That's because there remains systemic hurdles of access and cost.

Bhakdi said he understands those concerns. He had hoped originally to work with insurers to get the product out, but they required long-term economic studies to prove they would lower costs. Unable to produce that quickly, Quantgene moved to Santa Monica last year.

"We asked the question, 'What region has the most innovation-driven and future-oriented consumers and physicians and health care experts that are most likely to adopt new technologies?'," he said. "And what we found was very clear, very clear: Los Angeles."

In short, people in Los Angeles pay well to be healthy and beautiful. He pointed to companies that thrive in the metropolis like Next Health, a self-described longevity center that offers cryotherapy, or Remedy Place, a social wellness club.

"There's a big population here, a lot of whom are focused on health and wellness and are willing to spend the money," said David Whelan, chief executive of BioScienceLA, "The Goop effect sort of worked here. This is the place to be able to get a lot of customers very quickly when you're charging a high price point for customized service."

Beyond that, Bhakdi said there's also an extreme level of excellence in clinical infrastructure from medical institutions at UCLA, USC, City of Hope and Cedars-Sinai.

The move, he said, will hopefully allow Quantgene to demonstrate the product's value and convince insurers to offer it, eventually getting it into more people's hands. At the same time, the cost should draw down.

By 2024, the marketplace for personalized medicine and testing is expected to hit $85 billion, according to Pitchbook.

How does it work?

The company uses what's called cell-free DNA in the bloodstream to look for somatic mutations, those that are unrelated to hereditary factors and indicate a cancer growth.

"It's not a black and white thing," Bhakdi said.

It's more like matching different cancer profiles via machine learning. Using algorithms, the company traces the mutation patterns and compares those patterns to others who have the disease. By comparing the patient's mutation pattern along with their profile, Quantgene determines whether a specific cancer is maturing and tries to spot it.

"What the report does is not tell you whether you have cancer or not. That would be irresponsible," Bhakdi said. "It looks into the mutation pattern of the DNA that is in your gut — which means all the DNA that comes from, say, the diet in your body — and it takes these patterns and gives you a very high-resolution insight into how this compares with people with... all other kinds of medical conditions, including the ten leading cancers."

In 2016, Quantgene launched a clinical trial that will help them determine the sensitivity and specificity of the tests. Their goal is to have 10,000 patient blood samples. So far the company has about 5,000.

quantgeneQuantgene has developed a custom assay for DNA extractionCourtesy of Quantgene

But those working with the company think once it comes to market, it could be a game changer, helping physicians figure out how to deal with early signs of cancer.

"A lot of the companies working in molecular diagnostics don't have a good approach to telling physicians what to do and helping out with decision making. Quantgene has come to understand that that aspect of integrating clinical information and then providing guidance on what to do based on probabilities is helpful and necessary," said Jorge Nieva, an advisor to the company and an oncologist and associate professor at the University of Southern California Keck School of Medicine. "It has the real potential to revolutionize the field of cancer screening because our approach to cancer screening up to this point has really been organ-based."

What distinguishes the company, he said, is they are largely driven by math instead of biology.

"With the large database that Quantgene has built of some 40,000 tumors across 15 different cancers types, you can begin to build those patterns so that you can map those genetic abnormalities back to the anatomy," Nieva said.

https://twitter.com/racheluranga
rachel@dot.la
Forget Rockets, This Long Beach Startup Spins Satellites Into Orbit

🔦 Spotlight

Hello Los Angeles!

It may be scorching this weekend, but the real heat is coming out of Long Beach, where SpinLaunch just raised $30 million to accelerate its Meridian Space satellite constellation. If you’ve heard of SpinLaunch before, it’s probably because of its wild approach: instead of burning tons of rocket fuel, the company literally spins payloads in a giant centrifuge before releasing them into the sky. It sounds like science fiction, but it’s one of the boldest bets on making access to orbit cheaper, faster, and more sustainable.

Image Source: SpinLaunch

The new funding will go toward advancing Meridian Space, a low Earth orbit broadband network that aims to deliver flexible, affordable global connectivity. With its first customer links expected in 2026, the project has the potential to do more than beam internet. It could reshape how enterprises, defense networks, and communities around the world connect. For Los Angeles, it’s a reminder that our region isn’t just about building the next social app or entertainment platform. We’re also home to the companies trying to redefine the very infrastructure of the digital age.

And while space tech often feels far away, SpinLaunch keeps its roots planted firmly here. Its headquarters and orbital accelerator facility sit right in Long Beach, reinforcing Southern California’s reputation as a launchpad for both aerospace and climate conscious innovation. After all, swapping fuel heavy rockets for a ground based launch system isn’t just cost effective, it’s far greener.

So while you’re cranking the A/C this weekend, remember SpinLaunch is busy cranking satellites into orbit, proving once again that in Los Angeles we don’t just chase the stars, we spin new ways to reach them.

🤝 Venture Deals

LA Companies

    • Wellth, a Los Angeles–based digital health company focused on daily care motivation and behavior change strategies, has closed an oversubscribed $36M Series C round led by Mercato Partners. The funds will be used to expand access to its platform across Medicare Advantage, Medicaid, D SNP, and other high-need populations, while also accelerating product innovation including introducing generative AI capabilities to personalize engagement, backed by strong performance metrics like 90 percent care plan adherence, a 51 percent drop in inpatient admissions, and a 16 percent boost in medication adherence. - learn more

      LA Venture Funds

        • Presight Capital participated in General Fusion’s oversubscribed $22M financing round, helping the Canadian fusion energy company push forward with its LM26 demonstration program. The fresh capital will drive progress toward key scientific milestones in Magnetized Target Fusion technology such as high temperature plasma generation and renew momentum on the path to commercializing clean fusion energy. The round also brings new board members onboard to fortify leadership as General Fusion advances toward a zero carbon energy future. - learn more
        • B Capital led a new Series C strategic growth investment in CompanyCam. The construction tech platform, known for its AI-powered job site documentation and workflow tools, will use the funding to expand globally, deepen AI integration, and enhance product features. WndrCo also participated in the round, backing CompanyCam’s push to transform contractor productivity. - learn more
        • Clocktower Ventures participated in Relcu’s latest funding round. Relcu provides an AI powered “system of action” for financial services that helps institutions streamline workflows, improve customer engagement, and drive growth. The company will use the new capital to extend its CRM and AI Agent Co Pilot beyond mortgage into deposits, lending, and other areas by enhancing AI integration, expanding APIs, and embedding intelligent automation to boost conversion, retention, and cross sell. - learn more
        • UP Partners participated in Loft Dynamics’ latest $24M Series B funding round. The Swiss based VR flight training company will use the investment to expand its revolutionary pilot training solutions, built on FAA and EASA qualified VR simulators, into commercial aviation, launching full motion Boeing 737 and Airbus A320 systems alongside cloud connected, AI enhanced tools and immersive at home training kits. - learn more
        • Upfront Ventures led the $5.6M Series A funding for Agenda Hero. The San Francisco based AI platform helps users eliminate manual calendar work by transforming text, images, and PDFs into fully structured, shareable events and schedules. The new capital will accelerate AI features, expand calendar integrations, and scale adoption across individuals, teams, and organizations. - learn more
        • Thiel Capital participated in Stark’s latest $62M funding round, which was led by Sequoia Capital and brings the German startup's valuation to around $500 million. Stark, founded in 2024, specializes in AI powered loitering munitions and command and control systems for battlefield drones, and plans to use the fresh capital to enhance its autonomous navigation, swarming capabilities, and expand production into new markets like the UK. Doepfner Capital also joined the round, backing Stark’s push to scale its defense technology. - learn more
        • Crosscut Ventures and Vamos Ventures joined Aalo Atomics’ $100M Series B funding round, supporting the Austin‑based company’s mission to deploy modular nuclear reactors tailored for AI data centers. Aalo plans to build its first full-scale reactor, dubbed Aalo‑X, by next summer, co‑locating it with an experimental data center to showcase how factory‑produced nuclear plants can deliver clean, reliable power rapidly. This latest capital infusion accelerates Aalo’s deployment timeline and reinforces its strategy of mass manufacturing scalable nuclear infrastructure for the AI era. - learn more
        • Overture VC co-led a $7M seed round in ChemFinity Technologies to boost its deployment of modular, sorbent-based systems that recover over 20 critical minerals from waste streams at low cost. The funds will help the company pilot and scale its high-performance technology, enabling domestic recovery of valuable metals like rare earth elements and platinum, while reducing reliance on imports and lowering environmental impact. - learn more
        • Muse Capital led a high profile strategic investment in Ohai.ai, the AI powered household assistant founded by Care.com veteran Sheila Lirio Marcelo, joining a star studded lineup of backers including Olivia Munn, Mindy Kaling, and Abby Wambach. The new funding will accelerate Ohai.ai’s mission to relieve parental mental load, launching a back to school feature that lets families automatically sync school calendars by ZIP code or flyer, making household planning significantly smoother. - learn more
        • Navitas Capital, alongside other investors, participated in EliseAI’s $250M Series E funding round. The New York-based AI company automating complex systems in healthcare and housing, will use the new capital to rapidly scale its team, enhance product innovation, and accelerate deployment of its AI-powered automation platform across front-desk operations, resident services, and beyond. The company has already doubled its workforce since its Series D, surpassed $100 million in annual recurring revenue, and aims to expand its impact across multiple stressful sectors. - learn more
        • Bedrock participated in TensorZero’s $7.3M seed round to advance its open source infrastructure for building industrial grade LLM applications. TensorZero offers an integrated stack covering LLM gateways, observability, optimization, evaluation, and experimentation, all designed to create a data driven “learning flywheel” that turns feedback into smarter, faster model performance and is rapidly gaining traction with developers and enterprises alike. - learn more
        • Calibrate Ventures co-led a $6M seed round in Grid Aero, backing the aerospace startup’s debut of its Lifter Lite drone, an autonomous heavy lift aircraft designed to deliver thousands of pounds over long distances in challenging environments. The seed funding will drive testing and scaling efforts as Grid Aero readies for ground trials and positions the “pickup truck of the skies” as a low cost, modular logistics solution for military and future commercial use. - learn more
        • Chapter One participated in Hyperbeat’s oversubscribed $5.2M seed round. Hyperbeat will use the new capital to expand its suite of on-chain tools such as staking tokens, high yield vaults, credit layers, and portfolio tracking aimed at simplifying and enhancing DeFi yield generation for traders, protocols, and institutions. The round underscores growing institutional confidence in Hyperliquid’s expanding ecosystem, which recently surpassed $2.1 billion in total value locked. - learn more
            LA Exits
            • SpectrumAi has been acquired by CentralReach, a leading provider of autism and intellectual and developmental disabilities care software, alongside fellow acquisition AI.Measures. The deals expand CentralReach’s Care360 platform with advanced tools including predictive analytics, real time decision support, and individualized assessment capabilities that help providers deliver outcomes based care. Leadership from both acquired companies will join CentralReach, further strengthening its ability to empower providers, payors, and families with intelligent, results driven therapy solutions. - learn more

                      Download the dot.LA App

                      The Legal System Just Got Its AI Upgrade

                      🔦 Spotlight

                      Hello Los Angeles!

                      We talk a lot about AI in L.A., usually in the context of streaming platforms that “recommend” a movie you regret watching or apps that let you swap your face onto a Marvel poster. But the most interesting AI stories here aren’t gimmicks; they’re rewiring the hidden machinery of massive, slow moving industries. And this week, that spotlight falls on…lawyers.

                      LawPro.ai, a Los Angeles based legal tech startup, just closed a priced seed round led by Scopus Ventures to bring AI deeper into the world of injury claims. Their new “Case Assistant” isn’t about flashy automation, it’s about instantly surfacing case insights, cutting down endless hours of drafting, and helping law firms run with the precision of a Formula 1 pit crew.

                      Here’s why this matters: the legal industry has been one of the last holdouts when it comes to adopting tech that actually speeds things up. Now, with AI making its way from the red carpet to the courtroom, we’re watching the early stages of a shift that could change how justice is delivered in real time. In L.A., we’ve already seen AI startups shaking up entertainment, aerospace, and healthcare. Legal might be next.

                      And if LawPro.ai pulls it off, you might not just get a faster verdict, you might see the ripple effect across an industry that has spent decades charging by the hour. In other words, the billable clock might finally start running in our favor.


                      🤝 Venture Deals

                      LA Companies

                        • Equatic, a company using a patented seawater electrolysis process to remove atmospheric carbon dioxide while producing green hydrogen, has raised $11.6M in a Series A funding round. The round was co-led by Temasek Trust’s Catalytic Capital for Climate and Health (C3H) and Singapore-based Kibo Invest, and the capital will support the engineering, commercialization, and construction of its first 100‑kilotonne carbon removal facility, as well as broader manufacturing and technological development. - learn more
                        • SetPoint Medical has secured $140M in private financing, comprising a $25M second tranche of its Series C round and a $115M Series D round co-led by Elevage Medical Technologies and Ally Bridge Group. The funds will be used to launch and scale commercialization of the FDA approved SetPoint System, a pioneering neuroimmune modulation implant that targets the vagus nerve to treat moderate to severe rheumatoid arthritis, as well as to advance development of therapies for other autoimmune conditions. - learn more

                        LA Venture Funds

                          • Bonfire Ventures participated in Topline Pro’s $27M Series B funding round to help the company scale its AI driven platform for local home service businesses. Topline Pro provides tools for plumbers, landscapers, painters, and other service providers to manage websites, marketing, CRM, payments, and more, enabling them to operate as scalable, autonomous enterprises. The new funding will be used to enhance its AI agent suite and expand onboarding, customer success, and product development capabilities to deliver greater ROI for small businesses. - learn more
                          • B Capital participated in Isaac Health’s $10.5M Series A funding round, backing the company’s mission to expand access to brain health and dementia care. Isaac Health provides virtual and in-home services nationwide and will use the funds to enhance its AI-driven screening tools, strengthen its technology platform, and grow partnerships with health systems and payers. - learn more
                          • Bold Capital Partners joined a $44M Series C financing round for Gameto, a clinical stage biotech company developing stem cell derived reproductive therapies. The new funding, which brings Gameto’s total capital raised to approximately $127M, will support completion of its pivotal Phase 3 trial of Fertilo, an iPSC derived egg maturation therapy, and the company’s global regulatory filings and commercialization efforts. - learn more
                          • M13 led a seed round that raised $8.5M for Mako, a New York based AI startup focused on automating GPU code optimization. Mako’s platform lets developers write in familiar high level languages while its AI intelligently generates and continuously tunes low level GPU kernels, yielding faster performance, cost savings, and compatibility across hardware like NVIDIA, AMD, and Tenstorrent. The fresh funding will be used to expand the engineering team, deepen hardware support, and bring Mako’s performance tools to a broader audience in AI, graphics, simulation, and scientific computing. - learn more
                          • Rebel Fund participated in a $9M Series A round for Chowdeck, a profitable Nigerian food delivery startup aiming to build Africa’s next super app for food, groceries, and essentials. With this capital, Chowdeck plans to roll out its quick commerce strategy, powered by a network of dark stores and hyper local logistics, to speed up delivery across Nigeria and Ghana. - learn more
                            LA Exits
                            • Mayweather Boxing + Fitness has been acquired by Giant Ideas, LLC, alongside KickHouse, and will be combined with the company’s flagship brand Legends Boxing to form the largest skill based boutique fitness network with more than 70 studios worldwide. Rather than focusing solely on rapid expansion, the unified brands will prioritize operational excellence, franchisee success, and community driven skill development. - learn more

                                      Download the dot.LA App

                                      Locket, Disney, Instagram and the Battle for Your Attention

                                      🔦 Spotlight

                                      Happy Friday, Los Angeles!

                                      This week, LA’s biggest tech and media players made one thing clear: they want to own the relationship. Whether it’s a celebrity sending selfies straight to your home screen or a content giant rewriting the rules of sports broadcasting, the power shift toward more curated, direct experiences is unmistakable, and it’s being engineered right here.

                                      Image Source : Locket

                                      📸 Locket Doubles Down on Star Power

                                      Venice-based Locket, the viral photo sharing app that made homescreen widgets cool, is now leaning into what LA does best: celebrity. Its new feature, Celebrity Lockets, allows artists to send exclusive photos directly to fans’ home screens. Early adopters include Suki Waterhouse and JVKE, with creators curating limited fan access to maintain intimacy and exclusivity. As Locket evolves from a casual social tool into a direct fan engagement platform, it’s becoming an increasingly relevant player in LA’s creator tech ecosystem.

                                      🏈 Disney’s ESPN Plays Offense

                                      Disney made a trio of bold moves this week that solidify ESPN’s future and its dominance in sports media. It’s buying out the NFL’s stake in ESPN, securing exclusive NFL Draft and behind the scenes content through 2033, and finally giving its standalone ESPN streaming service a launch date: August 21, 2025. That’s a power play straight out of Burbank. At the same time, Disney announced it will no longer report individual subscriber numbers for Disney Plus and Hulu, signaling a shift in how it wants investors and maybe consumers to measure success.

                                      🗞️ The New York Post Bets on LA

                                      In a sign of LA’s growing national influence not just in entertainment, but in news, the New York Post is launching a West Coast vertical called The California Post. With an editorial mission to cover the state’s cultural and political pulse, this move reflects a broader trend of major media brands planting roots in LA to chase both readers and relevance. For local media startups, content creators, and civic tech players, it’s yet another sign that the competition and the opportunity is growing.

                                      Image Source: Meta

                                      📱 Instagram Wants Your Inner Circle

                                      Instagram rolled out a new set of features this week that prioritize connection with close friends. Users can now share what they’re doing, watching, or feeling with a smaller group, clearly borrowing from the intimacy playbooks of apps like BeReal, Snapchat, and yes, Locket. As social platforms shift from mass broadcast to curated circles, LA-based creators and consumer startups should take note: the next frontier might not be going viral, it might be going personal.

                                      From star-powered lockets to streaming shakeups and platform reinventions, this week’s stories highlight how LA’s tech and media companies are rewriting the rules on connection and control.

                                      Now onto this week’s venture deals 👇

                                      🤝 Venture Deals

                                      LA Venture Funds

                                        • Starburst co-invested in Madrid-based SpaceTech startup Orbital Paradigm’s €470,000 raise, part of an ongoing €2M funding round led by Akka. The company is developing reusable orbital re-entry capsules aimed at reducing costs and increasing sustainability for space missions. Starburst’s participation underscores its focus on backing innovative aerospace technologies with commercial and defense applications. - learn more
                                        • Rebel Fund participated in Orbital Operations’ $8.8M seed round, which came shortly after the company graduated from Y Combinator. The funding will support development of the company’s high-thrust orbital transfer vehicle, designed to maneuver satellites and other payloads in space more efficiently. - learn more
                                        • Fourth Revolution Capital participated in SuperGaming’s $15M Series B round, which valued the company at $100M, five times its previous valuation. The funds will help expand titles like Indus Battle Royale internationally and scale SuperGaming’s tools for developers in emerging markets. - learn more
                                        • Cedars-Sinai Health Ventures participated in Elion’s $9.3M seed round, joining NEA and others in backing the AI-powered healthcare research and intelligence platform. Elion helps over 60% of U.S. health systems evaluate emerging technologies through its structured vendor marketplace. The funds will support platform development, new product launches, market expansion, and team growth. - learn more
                                        • M13 led the $10M seed round for Kontext, an AI-powered contextual advertising startup emerging from stealth mode. Kontext’s platform enables real-time ads inside chatbot responses using large language models, and the funding will help expand its engineering team and develop image-based ad formats. - learn more
                                        • STORY3 Capital Partners made a significant minority investment in U.K.-based activewear brand Adanola, valuing the company at approximately $530 million. This strategic partnership brings STORY3’s deep experience in consumer brand scaling to support Adanola’s global expansion, particularly across the U.K. and U.S. markets. - learn more
                                        • Walkabout Ventures participated in OLarry’s $10M Series A round, which was led by TTV Capital and included Marin Sonoma Impact Ventures. The funding brings OLarry’s total capital raised to $14.5M and will be used to scale its AI-powered tax advisory platform for high-net-worth individuals and to acquire regional CPA firms as part of its growth strategy. - learn more
                                        • Glendon Capital Management participated in Grasshopper’s $46.6M funding round, which was led by Patriot Financial Partners, to support the bank’s merger with Auto Club Trust in April 2025. Their investment reflects confidence in Grasshopper’s ability to scale its digital banking platform and expand its suite of business and consumer financial products. Growth metrics as of June 30, 2025 showed a 53% increase in assets, an 81% surge in deposits, and a 49% rise in loans, all backed by this strategic capital infusion. - learn more
                                        • Mucker Capital participated in beatBread’s $124M capital raise, alongside Citi’s SPRINT team, Deciens Capital, and Advantage Capital. Their involvement supports beatBread’s strategy to expand sales, marketing, and technology operations, while enabling greater funding flexibility for independent artists, songwriters, and labels through its AI-powered platform. - learn more
                                        • B Capital co-led Positive Development’s $51.5M Series C funding round alongside aMoon and Flare Capital Partners, helping to fuel expansion of its developmental therapy model for autistic children. Their involvement underscores confidence in the company’s family-centered, play-based approach—which lowers costs by about 50% compared to traditional ABA therapy—and supports growth through new Medicaid partnerships and technology enhancements. - learn more
                                        • Clocktower Ventures participated in Creditop’s latest $3.7M funding round, which was led by Collide Capital and also included Alaya Capital, Amador Holdings, Newtopia, and Driven VC. Their involvement supports Creditop’s mission to enable credit access at the point of sale, without a credit card, and will help fintech deepen its footprint in Colombia while exploring expansion across Central America and Peru. - learn more
                                        • Thiel Capital participated in Pilgrim’s $4.3 million seed funding round, backing the biotech startup founded by 21-year-old Jake Adler after he demonstrated its hemostatic dressing, Kingsfoil, on himself. Their support underscores confidence in Pilgrim’s aggressive R&D and dual-use medical platform targeting both military and civilian emergency care. - learn more
                                        LA Exits
                                        • ElectroMagnetic Systems, Inc., a California-based specialist in AI and machine learning-powered target recognition software for space-based radar, has been acquired by Voyager. The deal strengthens Voyager’s AI-native surveillance and intelligence capabilities, enabling real-time monitoring across ground, air, and space domains to meet evolving defense and commercial demands. - learn more
                                        • Daring Foods is being acquired by Australia’s leading plant-based meat company, v2food, in a move that strengthens v2food’s push into the U.S. market. Daring will continue operating under its own brand and will serve as a platform to introduce v2food’s own products across the States. The deal, paired with a strategic partnership with Japanese food giant Ajinomoto, aims to accelerate innovation in clean-label protein and expand global reach. - learn more
                                        • Irwin Naturals is being acquired by FitLife Brands in an all-cash transaction valued at $42.5M, which includes approximately $16M in net working capital. The deal, expected to close around August 8, 2025, will nearly double FitLife’s scale, with projected combined annual revenue of over $120M and adjusted EBITDA between $20–25M. It will be funded with cash on hand, a new term loan, and a revolving credit facility, and is expected to generate synergies through complementary product lines, broader mass-market distribution, and improved operational efficiencies. - learn more
                                        • Solsniper, a Solana-focused trading and analytics platform known for high-speed memecoin execution, has been acquired by Phantom as part of its strategy to expand beyond wallets into full-service on-chain finance. The Solsniper team will join Phantom to enhance its advanced trading features, while the platform will continue operating independently. The move underscores Phantom’s ambition to offer seamless, integrated trading tools within the Solana ecosystem. - learn more
                                        • Cinelease is being acquired by Zello, a private investment platform dedicated to scaling businesses across the entertainment industry, in a strategic move to bolster production infrastructure and amplify its presence across North America. Under Zello’s ownership, Cinelease will continue operating as a standalone company led by its veteran team, enhancing its lighting, grip, and studio offerings for film, TV, and commercial productions. This acquisition sets the stage for disciplined growth and stronger relationships within the film and television production ecosystem. - learn more

                                                Download the dot.LA App

                                                RELATEDEDITOR'S PICKS
                                                Trending